(4S,5R)-2-(6-Benzhydrylpyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole, 97%, 250mg

H-Ala-pNA-HCl, 95.0%, 5g

(S)-tert-Butyl 1-(2-fluorobenzyl)pyrrolidin-3-ylcarbamate, 95.0%, 1g

(2S,4R)-1-Acetyl-4-hydroxypyrrolidine-2-carboxylic acid, 95.0%, 500g

((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid, 95.0%, 1g

Pyrazolo[1,5-a]pyrimidin-3-amine hydrochloride, 95.0%, 250mg

Barium oxide powder 99.5% -100 mesh 50 g

4-(Trifluoromethylthio)benzylamine>97.0%(GC)(T)1g

TERT-BUTYL (4-BROMO-5-CYANO-1-METHYL-1H-PYRAZOL-3-YL)(METHYL)CARBAMATE, 95.0%, 1g

7-Bromo-2-oxo-1,2-dihydroquinoline-4-carboxylic acid, 95%, 100mg

(R)-1-N-Cbz-Pyrrolidine-3-carboxylic acid, 95.0%, 1g

Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with ethyl (2R,3S)-2-[4-(cyclopentylamino)phenyl]-3-piperidinecarboxylate (2:1), 97%, 100mg

(R)-(6,6'-Dimethoxy-[1,1'-biphenyl]-2,2'-diyl)bis(diphenylphosphine), 97%, 100mg